Cargando…

TINF2 is a haploinsufficient tumor suppressor that limits telomere length

Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmutz, Isabelle, Mensenkamp, Arjen R, Takai, Kaori K, Haadsma, Maaike, Spruijt, Liesbeth, de Voer, Richarda M, Choo, Seunga Sara, Lorbeer, Franziska K, van Grinsven, Emma J, Hockemeyer, Dirk, Jongmans, Marjolijn CJ, de Lange, Titia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707837/
https://www.ncbi.nlm.nih.gov/pubmed/33258446
http://dx.doi.org/10.7554/eLife.61235
_version_ 1783617440814465024
author Schmutz, Isabelle
Mensenkamp, Arjen R
Takai, Kaori K
Haadsma, Maaike
Spruijt, Liesbeth
de Voer, Richarda M
Choo, Seunga Sara
Lorbeer, Franziska K
van Grinsven, Emma J
Hockemeyer, Dirk
Jongmans, Marjolijn CJ
de Lange, Titia
author_facet Schmutz, Isabelle
Mensenkamp, Arjen R
Takai, Kaori K
Haadsma, Maaike
Spruijt, Liesbeth
de Voer, Richarda M
Choo, Seunga Sara
Lorbeer, Franziska K
van Grinsven, Emma J
Hockemeyer, Dirk
Jongmans, Marjolijn CJ
de Lange, Titia
author_sort Schmutz, Isabelle
collection PubMed
description Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that truncate TIN2, a shelterin subunit that controls telomere length. Patient lymphocyte telomeres were unusually long. We show that the truncated TIN2 proteins do not localize to telomeres, suggesting that the mutations create loss-of-function alleles. Heterozygous knock-in of the mutations or deletion of one copy of TINF2 resulted in excessive telomere elongation in clonal lines, indicating that TINF2 is haploinsufficient for telomere length control. In contrast, telomere protection and genome stability were maintained in all heterozygous clones. The data establish that the TINF2 truncations predispose to a tumor syndrome. We conclude that TINF2 acts as a haploinsufficient tumor suppressor that limits telomere length to ensure a timely Hayflick limit.
format Online
Article
Text
id pubmed-7707837
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-77078372020-12-02 TINF2 is a haploinsufficient tumor suppressor that limits telomere length Schmutz, Isabelle Mensenkamp, Arjen R Takai, Kaori K Haadsma, Maaike Spruijt, Liesbeth de Voer, Richarda M Choo, Seunga Sara Lorbeer, Franziska K van Grinsven, Emma J Hockemeyer, Dirk Jongmans, Marjolijn CJ de Lange, Titia eLife Cancer Biology Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that truncate TIN2, a shelterin subunit that controls telomere length. Patient lymphocyte telomeres were unusually long. We show that the truncated TIN2 proteins do not localize to telomeres, suggesting that the mutations create loss-of-function alleles. Heterozygous knock-in of the mutations or deletion of one copy of TINF2 resulted in excessive telomere elongation in clonal lines, indicating that TINF2 is haploinsufficient for telomere length control. In contrast, telomere protection and genome stability were maintained in all heterozygous clones. The data establish that the TINF2 truncations predispose to a tumor syndrome. We conclude that TINF2 acts as a haploinsufficient tumor suppressor that limits telomere length to ensure a timely Hayflick limit. eLife Sciences Publications, Ltd 2020-12-01 /pmc/articles/PMC7707837/ /pubmed/33258446 http://dx.doi.org/10.7554/eLife.61235 Text en © 2020, Schmutz et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cancer Biology
Schmutz, Isabelle
Mensenkamp, Arjen R
Takai, Kaori K
Haadsma, Maaike
Spruijt, Liesbeth
de Voer, Richarda M
Choo, Seunga Sara
Lorbeer, Franziska K
van Grinsven, Emma J
Hockemeyer, Dirk
Jongmans, Marjolijn CJ
de Lange, Titia
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title_full TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title_fullStr TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title_full_unstemmed TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title_short TINF2 is a haploinsufficient tumor suppressor that limits telomere length
title_sort tinf2 is a haploinsufficient tumor suppressor that limits telomere length
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707837/
https://www.ncbi.nlm.nih.gov/pubmed/33258446
http://dx.doi.org/10.7554/eLife.61235
work_keys_str_mv AT schmutzisabelle tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT mensenkamparjenr tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT takaikaorik tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT haadsmamaaike tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT spruijtliesbeth tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT devoerrichardam tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT chooseungasara tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT lorbeerfranziskak tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT vangrinsvenemmaj tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT hockemeyerdirk tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT jongmansmarjolijncj tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength
AT delangetitia tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength